13 results
6-K
BLU
Bellus Health Inc
21 Apr 04
Current report (foreign)
12:00am
, for the prevention of
epileptic seizures that often follow traumatic brain injuries. Currently in
preclinical development, NC-1461 represents innovative technology
40-F
2021 FY
EX-99.3
BLU
Bellus Health Inc
23 Feb 22
Annual report (Canada)
5:20pm
, or, if they receive regulatory approval, our product candidates, becomes more widespread, illnesses, injuries, discomforts and other AEs that were observed
40-F
2021 FY
EX-99.1
BLU
Bellus Health Inc
23 Feb 22
Annual report (Canada)
5:20pm
candidates, becomes more widespread, illnesses, injuries, discomforts and other AEs that were observed in earlier trials, as well as conditions that did
SUPPL
BLU
Bellus Health Inc
14 Nov 22
Supplemental materials (foreign)
5:25pm
extensive clinical trials, illnesses, injuries, discomforts and other AEs that were observed in earlier trials, as well as conditions that did not occur … and more extensive clinical trials, illnesses, injuries, discomforts and other AEs that were observed in earlier trials, as well as conditions
6-K
BLU
Bellus Health Inc
10 Nov 03
Current report (foreign)
12:00am
-1461 as its drug candidate to prevent
epileptic seizures that often follow traumatic brain injuries.
A LARGE POPULATION TARGETED
In the United States
6-K
EX-99.1
9gno9o0ungpwzfkg
5 Apr 22
Current report (foreign)
4:07pm
6-K
EX-99.1
2cjvenrq
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.1
5bwnfq8kcph5fl22wj
30 Apr 09
Current report (foreign)
12:00am
6-K
EX-99.2
wsb6g0l1d2o
30 Apr 09
Current report (foreign)
12:00am
F-10
wgr6a
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
sorj7n3
13 Nov 06
Current report (foreign)
12:00am
SUPPL
93g9fe8f 8ku
15 Jul 22
Supplemental materials (foreign)
7:01am
SUPPL
7895 56qm
13 Jul 22
Supplemental materials (foreign)
5:01pm
- Prev
- 1
- Next